|
|
Volumn 54, Issue 17, 1997, Pages 1922-1925
|
|
Pramipexole marketed for Parkinson's disease
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMANTADINE;
ANTIPARKINSON AGENT;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
PLACEBO;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
TOLCAPONE;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG APPROVAL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MARKETING;
DYSKINESIA;
EXTRAPYRAMIDAL SYMPTOM;
HALLUCINATION;
HUMAN;
INSOMNIA;
NAUSEA;
NOTE;
ON OFF PHENOMENON;
ORAL DRUG ADMINISTRATION;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
VERTIGO;
|
|
EID: 0030868325
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/54.17.1922 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|